• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗逆转录病毒 APOBEC3 胞嘧啶脱氨酶改变 HIV-1 前病毒整合位点谱。

Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.

机构信息

Western University, Schulich School of Medicine and Dentistry, Department of Microbiology and Immunology, London, ON, Canada.

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

出版信息

Nat Commun. 2023 Jan 10;14(1):16. doi: 10.1038/s41467-022-35379-y.

DOI:10.1038/s41467-022-35379-y
PMID:36627271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9832166/
Abstract

APOBEC3 (A3) proteins are host-encoded deoxycytidine deaminases that provide an innate immune barrier to retroviral infection, notably against HIV-1. Low levels of deamination are believed to contribute to the genetic evolution of HIV-1, while intense catalytic activity of these proteins can induce catastrophic hypermutation in proviral DNA leading to near-total HIV-1 restriction. So far, little is known about how A3 cytosine deaminases might impact HIV-1 proviral DNA integration sites in human chromosomal DNA. Using a deep sequencing approach, we analyze the influence of catalytic active and inactive APOBEC3F and APOBEC3G on HIV-1 integration site selections. Here we show that DNA editing is detected at the extremities of the long terminal repeat regions of the virus. Both catalytic active and non-catalytic A3 mutants decrease insertions into gene coding sequences and increase integration sites into SINE elements, oncogenes and transcription-silencing non-B DNA features. Our data implicates A3 as a host factor influencing HIV-1 integration site selection and also promotes what appears to be a more latent expression profile.

摘要

APOBEC3(A3)蛋白是宿主编码的脱氧胞嘧啶脱氨酶,为逆转录病毒感染提供先天免疫屏障,特别是针对 HIV-1。据信,低水平的脱氨作用有助于 HIV-1 的遗传进化,而这些蛋白的强烈催化活性可诱导前病毒 DNA 发生灾难性的超突变,导致 HIV-1 几乎完全受到限制。到目前为止,人们对 A3 胞嘧啶脱氨酶如何影响 HIV-1 前病毒 DNA 整合到人类染色体 DNA 中的位置知之甚少。我们使用深度测序方法分析了催化活性和非活性 APOBEC3F 和 APOBEC3G 对 HIV-1 整合位点选择的影响。在这里,我们表明在病毒的长末端重复区域的末端检测到 DNA 编辑。催化活性和非催化 A3 突变体均减少插入基因编码序列,并增加插入到 SINE 元件、癌基因和转录沉默非 B DNA 特征的整合位点。我们的数据表明 A3 是影响 HIV-1 整合位点选择的宿主因素,并促进了似乎更潜伏的表达谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/79608ec5e032/41467_2022_35379_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/a19f5c61e7c6/41467_2022_35379_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/669d87e420d0/41467_2022_35379_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/bcd2665df00f/41467_2022_35379_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/305bbbb655d6/41467_2022_35379_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/9b15a237bca3/41467_2022_35379_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/ec7e1e84e3b2/41467_2022_35379_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/18caf74b4ba6/41467_2022_35379_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/79608ec5e032/41467_2022_35379_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/a19f5c61e7c6/41467_2022_35379_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/669d87e420d0/41467_2022_35379_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/bcd2665df00f/41467_2022_35379_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/305bbbb655d6/41467_2022_35379_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/9b15a237bca3/41467_2022_35379_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/ec7e1e84e3b2/41467_2022_35379_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/18caf74b4ba6/41467_2022_35379_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/9832166/79608ec5e032/41467_2022_35379_Fig8_HTML.jpg

相似文献

1
Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.抗逆转录病毒 APOBEC3 胞嘧啶脱氨酶改变 HIV-1 前病毒整合位点谱。
Nat Commun. 2023 Jan 10;14(1):16. doi: 10.1038/s41467-022-35379-y.
2
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.病毒体共包装胞苷脱氨酶APOBEC3F和APOBEC3G增强HIV限制的机制
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
3
Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.急性/早期和慢性感染患者的HIV-1上可能存在APOBEC3F和/或其他APOBEC3脱氨酶而非APOBEC3G的痕迹。
J Virol. 2014 Nov;88(21):12882-94. doi: 10.1128/JVI.01460-14. Epub 2014 Aug 27.
4
APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.APOBEC3 宿主限制因子可改变逆转录酶的模板转换频率。
J Mol Biol. 2019 Mar 29;431(7):1339-1352. doi: 10.1016/j.jmb.2019.02.015. Epub 2019 Feb 22.
5
Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.HIV-1 G 到 A 超突变和限制在非允许性 T 细胞系 CEM2n 中的内源性起源。
PLoS Pathog. 2012;8(7):e1002800. doi: 10.1371/journal.ppat.1002800. Epub 2012 Jul 12.
6
Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.人载脂蛋白B mRNA编辑酶催化多肽样蛋白3诱导的1型人类免疫缺陷病毒突变有助于自然感染中的适应和进化。
PLoS Pathog. 2014 Jul 31;10(7):e1004281. doi: 10.1371/journal.ppat.1004281. eCollection 2014 Jul.
7
Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.APOBEC3F 的催化活性是限制 Vif 缺陷型人类免疫缺陷病毒所必需的。
Virology. 2014 Feb;450-451:49-54. doi: 10.1016/j.virol.2013.11.041. Epub 2013 Dec 20.
8
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.在不存在超突变的情况下,载脂蛋白B mRNA编辑酶催化多肽样3F(APOBEC3F)可抑制HIV-1逆转录产物的积累。与载脂蛋白B mRNA编辑酶催化多肽样3G(APOBEC3G)的比较。
J Biol Chem. 2007 Jan 26;282(4):2587-95. doi: 10.1074/jbc.M607298200. Epub 2006 Nov 22.
9
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.单结构域的载脂蛋白B mRNA编辑酶催化多肽样蛋白3C(APOBEC3C)与双结构域的载脂蛋白B mRNA编辑酶催化多肽样蛋白3F/G(APOBEC3F/G)抗逆转录病毒胞苷脱氨酶的突变比较,有助于深入了解它们的DNA靶位点特异性。
Nucleic Acids Res. 2005 Apr 4;33(6):1913-23. doi: 10.1093/nar/gki343. Print 2005.
10
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.载脂蛋白B mRNA编辑酶催化多肽样蛋白(APOBEC)的抗病毒效力与胞苷脱氨基作用无关。
J Virol. 2006 Sep;80(17):8450-8. doi: 10.1128/JVI.00839-06.

引用本文的文献

1
Mechanism of deamination by mycobacterial deaminase selectively targeting mutagenic bases.分枝杆菌脱氨酶选择性靶向诱变碱基的脱氨机制。
Nucleic Acids Res. 2025 Mar 20;53(6). doi: 10.1093/nar/gkaf171.
2
APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.与载脂蛋白B mRNA编辑酶催化多肽样蛋白3相关的HIV-1和HTLV-1限制的编辑及非编辑决定因素
Int J Mol Sci. 2025 Feb 12;26(4):1561. doi: 10.3390/ijms26041561.
3
Regulation of viral replication by host restriction factors.宿主限制因子对病毒复制的调控。

本文引用的文献

1
Human transposons are an abundant supply of transcription factor binding sites and promoter activities in breast cancer cell lines.人类转座子是乳腺癌细胞系中转录因子结合位点和启动子活性的丰富来源。
Mob DNA. 2019 Apr 27;10:16. doi: 10.1186/s13100-019-0158-3. eCollection 2019.
2
Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration.衣壳-CPSF6 相互作用使核 HIV-1 易位到病毒 DNA 整合的部位。
Cell Host Microbe. 2018 Sep 12;24(3):392-404.e8. doi: 10.1016/j.chom.2018.08.002. Epub 2018 Aug 30.
3
Characterization of molecular attributes that influence LINE-1 restriction by all seven human APOBEC3 proteins.
Front Immunol. 2025 Jan 23;16:1484119. doi: 10.3389/fimmu.2025.1484119. eCollection 2025.
4
Getting the job done right requires the right tools: Increased CAR T cell efficiency with improved packaging cell line.把工作做好需要合适的工具:通过改进包装细胞系提高嵌合抗原受体T细胞(CAR T)的效率。
Mol Ther Oncol. 2024 Nov 15;32(4):200901. doi: 10.1016/j.omton.2024.200901. eCollection 2024 Dec 19.
5
Host cell restriction factors of equine infectious anemia virus.马传染性贫血病毒的宿主细胞限制因子。
Virol Sin. 2023 Aug;38(4):485-496. doi: 10.1016/j.virs.2023.07.001. Epub 2023 Jul 5.
6
Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses.特异性 DNA 结构可作为进化多样化的逆转录病毒整合的基因组信标。
Viruses. 2023 Feb 7;15(2):465. doi: 10.3390/v15020465.
鉴定影响七种人类 APOBEC3 蛋白对 LINE-1 限制的分子特征。
Virology. 2018 Jul;520:127-136. doi: 10.1016/j.virol.2018.05.015. Epub 2018 May 31.
4
Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4 T cells.不同的染色质功能状态与感染的原代 CD4 T 细胞中的 HIV 潜伏期再激活相关。
Elife. 2018 May 1;7:e34655. doi: 10.7554/eLife.34655.
5
HIV integration sites and implications for maintenance of the reservoir.HIV 整合位点及其对储库维持的影响。
Curr Opin HIV AIDS. 2018 Mar;13(2):152-159. doi: 10.1097/COH.0000000000000438.
6
Computational Model and Dynamics of Monomeric Full-Length APOBEC3G.单体全长载脂蛋白B编辑酶催化多肽样蛋白3G的计算模型与动力学
ACS Cent Sci. 2017 Nov 22;3(11):1180-1188. doi: 10.1021/acscentsci.7b00346. Epub 2017 Oct 20.
7
Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G.深度测序 HIV-1 逆转录酶揭示了 APOBEC3G 的多方面抗病毒功能。
Nat Microbiol. 2018 Feb;3(2):220-233. doi: 10.1038/s41564-017-0063-9. Epub 2017 Nov 20.
8
APOBEC Enzymes as Targets for Virus and Cancer Therapy.APOBEC 酶作为病毒和癌症治疗的靶点。
Cell Chem Biol. 2018 Jan 18;25(1):36-49. doi: 10.1016/j.chembiol.2017.10.007. Epub 2017 Nov 16.
9
Nuclear landscape of HIV-1 infection and integration.HIV-1 感染和整合的核景观。
Nat Rev Microbiol. 2017 Feb;15(2):69-82. doi: 10.1038/nrmicro.2016.162. Epub 2016 Dec 12.
10
Position effects influence HIV latency reversal.位置效应影响 HIV 潜伏期逆转。
Nat Struct Mol Biol. 2017 Jan;24(1):47-54. doi: 10.1038/nsmb.3328. Epub 2016 Nov 21.